Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Seattle Genetics Shares Trade Higher on Q1/20 Earnings and 22% Growth in ADCETRIS Sales

Seattle Genetics shares traded 8% higher, reaching a new 52-week high, after the company reported Q1/20 financial results which included a 10% y-o-y increase in net revenues fueled by a 22% increase in sales of ADCETRIS® and a strong debut for PADCEV™ in its first f...

Buzz on the Bullboards: Gold and Psychedelics Shake Up the Top

In a time of renewed uncertainty in the markets, investors tend to focus on the more consistent plays. The recent wave of uncertainty follows the earlier wave, both caused by increases in COVID-19 coronavirus cases and worries over the state of the economy. At first it ha...

Europe steps on the gas! E-mobility and secure supply chains - Avrupa Minerals, BYD, VW, and Stellan

The stock market year has gotten off to a turbulent start, but a new megatrend is gaining traction: critical metals! While 2025 was dominated by AI and high-tech stocks, raw material suppliers, essential for maintaining industrial competitiveness, are increasingly mo...

What is the future of oil and gas?

Population growth will be a massive factor on increased energy demands The International Energy Agency states that at present we are “maintaining the 2021 energy crisis” The push for renewables as we head towards 2050 doesn&CloseC...

Living in a virus-controlled world

As the coronavirus pandemic continues to infect populations, though in some countries it is slowing, talk has shifted to re-opening economies, and to manufacturing a vaccine that drug companies hope will not only work, but can be distributed at large enough doses to provide ...

Silver’s Q4 Seasonal Outlook

What has been will be again, what has been done will be done again; there is nothing new under the sun. Ecclesiastes 1:9 History repeats itself. Not always, and not 100%, but often enough and to an extent that’s significant enough to make these repet...

David Smith: 'Common Sense 2.0' Is a Call to Action to Hold Government Accountable

Maurice Jackson: Today, we're going to discuss a very, very important topic and that is debt slavery. We're also going to discuss common sense, and more importantly, what actions you need to take to protect your family. Joining us for a conversation is David Smith from m...

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. Healthcare company Myovant Sciences Ltd. (...

This Signal Points To More Upside In Stocks

NEW MONTHLY SIGNALS The MSCI World Index tracks over one thousand large and mid-cap stocks in twenty-two developed countries, covering 85% of the market capitalization in those regions. As shown via the chart below, a positive monthly MACD cross was just nailed down on the...

NASDAQ Listing & $100M Sales Guidance Fuels Peak’s H2/21

eResearch is pleased to publish an update Equity Research Report on Peak Fintech Group (PKK) ( CSE.PKK , OTC: PKKFF , Forum ) pertaining to the recent release of its revenue & EBITDA guidance. We are maintaining our Speculative Buy rating and increasing our one-year pr...
1 2 3 4 5 6 7 8 9 10 ...